Using the ResCu system for preclinical testing of KRAS G12C inhibitors

被引:0
|
作者
Ruiz, Victor M. [1 ]
Hill, Lindsay [1 ]
Gadde, Manasa [1 ]
Bulow, Christopher [1 ]
Morri, Maurizio [1 ]
Goldner, Nicholas [1 ]
机构
[1] ResistanceBio, San Carlos, CA USA
关键词
D O I
10.1158/1557-3125.RAS23-B030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B030
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
    Lito, Piro
    Solomon, Martha
    Hansen, Rasmus
    Li, Lian-Sheng
    Rosen, Neal
    CANCER RESEARCH, 2016, 76
  • [42] The emerging target KRAS G12C in genitourinary malignancies
    Grivas, Petros
    Necchi, Andrea
    Bratslavsky, Gennady
    Shapiro, Oleg
    Jacob, Joseph
    Elvin, Julia Andrea
    Vergilio, Jo-Anne
    Killian, Keith
    Williams, Erik
    Ramkissoon, Shakti H.
    Severson, Eric Allan
    Hemmerich, Amanda
    Schrock, Alexa Betzig
    Chung, Jon
    McGregor, Kimberly
    Reddy, Prasanth
    Alexander, Brian Michael
    Sokol, Ethan
    Danziger, Natalie
    Ross, Jeffrey S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [43] Two new agents target KRAS G12C
    Diana Romero
    Nature Reviews Clinical Oncology, 2020, 17 (1) : 6 - 6
  • [44] Immunogenomics of Clinical Resistance to KRAS G12C Inhibition
    Woodcock, M.
    Tsai, Y. S.
    Azam, S. H.
    Thorne, L. B.
    Kanchi, K. L.
    Parker, J. S.
    Vincent, B. G.
    Pecot, C. V.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S599 - S600
  • [45] Two new agents target KRAS G12C
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (01) : 6 - 6
  • [46] LANDSCAPE OF KRAS G12C MUTATIONS IN GENITOURINARY MALIGNANCIES
    Rebecca, Sager A.
    Michael, Basin F.
    Hanan, Goldberg
    Jeffrey, Ross S.
    Gennady, Bratslavsky
    Joseph, Jacob M.
    Petros, Grivas
    Andrea, Necchi
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S69 - S69
  • [47] Targeting KRAS G12C mutation in lung adenocarcinoma
    Rohatgi, Anjali
    Govindan, Ramaswamy
    LUNG CANCER, 2022, 165 : 28 - 33
  • [48] Targeting KRAS G12C mutations in colorectal cancer
    Zhao, Ming-He
    Wu, Ai-Wen
    GASTROENTEROLOGY REPORT, 2023, 11
  • [49] KRAS G12C inhibition and innate immune targeting
    Tani, Tetsuo
    Kitajima, Shunsuke
    Conway, Ella B.
    Knelson, Erik H.
    Barbie, David A.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (03) : 167 - 174
  • [50] Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
    Cucurull, Marc
    Notario, Lucia
    Sanchez-Cespedes, Montse
    Hierro, Cinta
    Estival, Anna
    Carcereny, Enric
    Saigi, Maria
    FRONTIERS IN ONCOLOGY, 2022, 11